The role of SMARCB1/INI1 in development of rhabdoid tumor

被引:152
作者
Roberts, Charles W. M. [3 ]
Biegel, Jaclyn A. [1 ,2 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Harvard Univ, Childrens Hosp, Dept Pediat Oncol, Dana Farber Canc Inst,Sch Med,Div Hematol Oncol, Boston, MA 02115 USA
关键词
rhabdoid tumor; retroperitoneum; angiogenesis; surgery; chemotherapy; radiotherapy; targeted therapy; recurrence; metastasis; CHROMATIN-REMODELING COMPLEX; ATYPICAL TERATOID/RHABDOID TUMORS; STRAND BREAK REPAIR; CELL-CYCLE ARREST; DNA-DAMAGE; SUPPRESSOR GENE; HSNF5/INI1; GENE; IMMUNOHISTOCHEMICAL ANALYSIS; MOLECULAR CHARACTERIZATION; FAMILIAL SCHWANNOMATOSIS;
D O I
10.4161/cbt.8.5.8019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A note about nomenclature: The ortholog of the gene mutated in rhabdoid tumors was first studied in yeast where it was identified in a screen for mutants incapable of fermenting sucrose. It was thus given the name Sucrose Non-Fermenting gene number 5 (SNF5) and was subsequently found to be a member of the SWI/SNF chromatin remodeling complex. The human ortholog of the gene was identified in a screen for proteins capable of interacting with the integrase protein of the human immunodeficiency virus and was given the name INtegrase Interactor 1 (INI1). Investigators studying a mammalian version of the Swi/Snf complex felt that its function may have diverged somewhat from the yeast complex and thus proposed renaming the complex the Brg1/Brm Associated Factors complex, or BAF complex. The rhabdoid tumor gene was thus given the name BAF47 based upon its apparent molecular mass of 47 Kd. Most recently, the genetic nomenclature committee bestowed the name SMARCB1 for SWI/SNF related, Matrix associated, Actin dependent Regulator of Chromatin, subfamily B, member 1. Each of these names has been used extensively in the literature and we ourselves have referred to the gene as either SNF5 (CWMR) or INI1 (JAB). In an effort to simplify communication, we have chosen to use the official SMARCB1 nomenclature here.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 50 条
  • [31] Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience
    Bell, Diana
    Hanna, Ehab Y.
    Agaimy, Abbas
    Weissferdt, Annikka
    VIRCHOWS ARCHIV, 2015, 467 (06) : 649 - 656
  • [32] SMARCB1/INI1-Deficient Extrarenal Rhabdoid Tumor: A Case Report of a Rare and Aggressive Soft Tissue Sarcoma
    Parker, Nathaniel A.
    Al-Obaidi, Ammar
    Lalich, Daniel
    Deutsch, Jeremy M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [33] The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report
    Kazushi Yoshida
    Yutaka Fujiwara
    Yasushi Goto
    Takashi Kohno
    Akihiko Yoshida
    Koji Tsuta
    Yuichiro Ohe
    BMC Cancer, 18
  • [34] Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis
    Hasselblatt, Martin
    Thomas, Christian
    Hovestadt, Volker
    Schrimpf, Daniel
    Johann, Pascal
    Bens, Susanne
    Oyen, Florian
    Peetz-Dienhart, Susanne
    Crede, Yvonne
    Wefers, Annika
    Vogel, Hannes
    Riemenschneider, Markus J.
    Antonelli, Manila
    Giangaspero, Felice
    Bernardo, Marie Christine
    Giannini, Caterina
    Din, Nasir Ud
    Perry, Arie
    Keyvani, Kathy
    van Landeghem, Frank
    Sumerauer, David
    Hauser, Peter
    Capper, David
    Korshunov, Andrey
    Jones, David T. W.
    Pfister, Stefan M.
    Schneppenheim, Reinhard
    Siebert, Reiner
    Fruehwald, Michael C.
    Kool, Marcel
    ACTA NEUROPATHOLOGICA, 2016, 132 (01) : 149 - 151
  • [35] SMARCB1 (INI-1)-deficient Carcinomas of the Sinonasal Tract
    Bishop, Justin A.
    Antonescu, Cristina R.
    Westra, William H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (09) : 1282 - 1289
  • [36] Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: An experience at a Tertiary Cancer Referral Centre
    Rekhi, Bharat
    Jambhekar, Nirmala A.
    PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (12) : 758 - 766
  • [37] Utility of characteristic "Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovialsarcomas
    Rekhi, Bharat
    Vogel, Ulrich
    APMIS, 2015, 123 (07) : 618 - 628
  • [38] SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
    Brenca, Monica
    Rossi, Sabrina
    Lorenzetto, Erica
    Piccinin, Elena
    Piccinin, Sara
    Rossi, Francesca Maria
    Giuliano, Alberto
    Tos, Angelo Paolo Dei
    Maestro, Roberta
    Modena, Piergiorgio
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 1060 - 1072
  • [39] Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
    Bourdeaut, Franck
    Lequin, Delphine
    Brugieres, Laurence
    Reynaud, Stephanie
    Dufour, Christelle
    Doz, Francois
    Andre, Nicolas
    Stephan, Jean-Louis
    Perel, Yves
    Oberlin, Odile
    Orbach, Daniel
    Bergeron, Christophe
    Rialland, Xavier
    Freneaux, Paul
    Ranchere, Dominique
    Figarella-Branger, Dominique
    Audry, Georges
    Puget, Stephanie
    Evans, D. Gareth
    Ferreres Pinas, Joan Carles
    Capra, Valeria
    Mosseri, Veronique
    Coupier, Isabelle
    Gauthier-Villars, Marion
    Pierron, Gaelle
    Delattre, Olivier
    CLINICAL CANCER RESEARCH, 2011, 17 (01) : 31 - 38
  • [40] Conventional Chondrosarcoma in a Survivor of Rhabdoid Tumor Enlarging The Spectrum of Tumors Associated With SMARCB1 Germline Mutations
    Forest, Fabien
    David, Audrey
    Arrufat, Sandrine
    Pierron, Gaelle
    Ranchere-Vince, Dominique
    Stephan, Jean-Louis
    Clemenson, Alix
    Delattre, Olivier
    Bourdeaut, Franck
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (12) : 1892 - 1896